The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...

President Donald Trump and Republicans in Congress should take several steps to further restrict abortion and protect human ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

This story was originally published by Grist with the headline As climate change supercharges disease, Trump pulls US from ...

Retailers now have less than one year to meet the requirements of section 204 of the Food Safety Modernization Act (FSMA), ...

The company formerly known as Athletic Greens is expanding its market beyond the self-optimizers that follow the podcasters ...

President Trump's new policy restricts federal health agencies from publishing external communications, raising concerns ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.